DNA Methylation in Urological Cancers

作者: Wolfgang A. Schulz , Hans-Helge Seifert

DOI: 10.1007/0-387-27443-X_4

关键词:

摘要: Urological cancers are a diverse group with different alterations of DNA methylation. In all urological cancers, hypermethylation specific genes has been described. contrast, methylation repetitive sequences is often diminished, resulting in decreased overall levels (“global hypomethylation”). Altered imprinting also found. Testicular tumors derived from more or less immature germ cells whose patterns they reflect. Subtypes can be distinguished by the extents global hypomethylation and hypermethylation. Renal cell carcinomas typically display restricted to important for tumor development progression. By comparison, severely disturbed prostate bladder which multiple coexists genome-wide hypomethylation. Causes altered may differ. Hypermethylation could incidental renal but likely caused primary defects machinery still undefined. However, potential influences diet chemical carcinogens need better understood. acts as an mechanism silencing suppressor genes. Global correlates chromosomal instability. The underlying this association not detected urine, ejaculate, blood tissue biopsies. assays improve detection, monitoring, staging classification near future employed select patient-adapted therapies. efficacy, application range risk inducing progression drugs targeting yet determined cancers. diversity these require carefully adapted approach optimal exploitation their alterations.

参考文章(146)
E R Maher, F M Richards, A R Webster, N A Affara, A H Prowse, F Resche, S Richard, S Olschwang, Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. American Journal of Human Genetics. ,vol. 60, pp. 765- 771 ,(1997)
Bernd J. Schmitz-Dräger, Wolfgang A. Schulz, Bettina Jürgens, Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Research. ,vol. 56, pp. 5698- 5703 ,(1996)
Wei Lou, Diane Krill, Rajiv Dhir, Michael J Becich, Jin-Tang Dong, Henry F Frierson Jr, William B Isaacs, John T Isaacs, Allen C Gao, None, Methylation of the CD44 metastasis suppressor gene in human prostate cancer Cancer Research. ,vol. 59, pp. 2329- 2331 ,(1999)
Steven C. Clifford, Eamonn R. Maher, von Hippel-Lindau disease: Clinical and molecular perspectives Advances in Cancer Research. ,vol. 82, pp. 85- 105 ,(2001) , 10.1016/S0065-230X(01)82003-0
Sabine Zöchbauer-Müller, Arthur Sagalowsky, John D. Minna, Bogdan Czerniak, Funda Vakar-Lopez, Adi F. Gazdar, Shinichi Toyooka, Arvind K. Virmani, Alfredo J. Farinas, Kiyomi O. Toyooka, Kenichi Harada, Riichiroh Maruyama, Aberrant Promoter Methylation Profile of Bladder Cancer and Its Relationship to Clinicopathological Features Cancer Research. ,vol. 61, pp. 8659- 8663 ,(2001)
Laurie Jackson-Grusby, Caroline Beard, Richard Possemato, Matthew Tudor, Douglas Fambrough, Györgyi Csankovszki, Jessica Dausman, Peggy Lee, Christopher Wilson, Eric Lander, Rudolf Jaenisch, Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nature Genetics. ,vol. 27, pp. 31- 39 ,(2001) , 10.1038/83730
Mihaela Velicescu, Daniel J. Weisenberger, Felicidad A. Gonzales, Peter A. Jones, Carvell T. Nguyen, Yvonne C. Tsai, Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Research. ,vol. 62, pp. 2378- 2384 ,(2002)
Keith D. Robertson, Slimane Ait-Si-Ali, Tomoki Yokochi, Paul A. Wade, Peter L. Jones, Alan P. Wolffe, DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters Nature Genetics. ,vol. 25, pp. 338- 342 ,(2000) , 10.1038/77124
Hue-Kian Oh, Eileen Hwee-Hong Tan, Linda Shyue-Huey Chuang, Benjamin F-L. Li, Selective depletion of human DNA-methyltransferase DNMT1 proteins by sulfonate-derived methylating agents. Cancer Research. ,vol. 62, pp. 1592- 1597 ,(2002)
M Oya, W A Schulz, Decreased expression of p57(KIP2)mRNA in human bladder cancer. British Journal of Cancer. ,vol. 83, pp. 626- 631 ,(2000) , 10.1054/BJOC.2000.1298